Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I, in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
Fox Chase Cancer Center (INC)
Search grants from Fox Chase Cancer Center (INC)
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Role of Target DNA sequences in mutation and DNA Break Generation
Environment Influences Upon Auditory Development
Saa Lipoprotein Family - Function & Role in Amyloidosis
Signal Transduction by Protein Phosphorylation
Workshop on the Application of Fluid Mechanics to Materials Processing, September 13-15, 1987, University of California (Berkeley)
Recently added grants:
Biomimetic Virulomics for Capture and Identification of Cell-Type Specific EffectorProteins
HSV-2 specificity and phenotyping of tissue-based T cells in genital skin biopsies of HSV-2 reactivation
Phosphate homeostasis and uptake in Staphylococcus aureus
The pig: A novel large animal model of allergic eosinophilic esophagitis
Paneth cell-specific IL-22Ra1 signaling in mucosal host defense
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025120-000
Application #
6688661
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center (INC)
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
Phase I, in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
/ Fox Chase Cancer Center (INC)
NIH 2002
N01 CA
Phase I, in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
/ Fox Chase Cancer Center (INC)
Comments
Be the first to comment on this grant